Overlapping transcriptional programs regulated by the nuclear receptors peroxisome proliferator-activated receptor α, retinoid X receptor, and liver X receptor in mouse liver

被引:74
作者
Anderson, SP
Dunn, C
Laughter, A
Yoon, L
Swanson, C
Stulnig, TM
Steffensen, KR
Chandraratna, RAS
Gustafsson, JÅ
Corton, JC
机构
[1] ToxicoGenomics, Chapel Hill, NC 27514 USA
[2] GlaxoSmithKline Res & Dev, Safety Assessment, Invest Toxicol & Pathol Grp, Res Triangle Pk, NC USA
[3] CIIT Ctr Hlth Res, Div Biol Sci, Res Triangle Pk, NC USA
[4] Univ Vienna, Dept Internal Med 3, Vienna, Austria
[5] Austrian Acad Sci, Ctr Mol Med, A-1010 Vienna, Austria
[6] Karolinska Inst, Novum, Dept Biosci, Huddinge, Sweden
[7] Karolinska Inst, Novum, Dept Med Nutr, Huddinge, Sweden
[8] Allergan Pharmaceut Inc, Retinoid Res, Dept Chem, Irvine, CA 92715 USA
[9] Allergan Pharmaceut Inc, Retinoid Res, Dept Biol, Irvine, CA 92715 USA
关键词
D O I
10.1124/mol.104.005496
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Lipid homeostasis is controlled in part by the nuclear receptors peroxisome proliferator (PP)-activated receptor alpha (PPARalpha) and liver X receptor (LXR) through regulation of genes involved in fatty acid and cholesterol metabolism. Exposure to agonists of retinoid X receptor (RXR), the obligate heterodimer partner of PPARalpha, and LXR results in responses that partially overlap with those of PP. To better understand the gene networks regulated by these nuclear receptors, transcript profiles were generated from the livers of wild-type and PPARalpha-null mice exposed to the RXR pan-agonist 3,7-dimethyl-6S, 7S-methano, 7-[1,1,4,4-tetramethyl-1,2,3,4-tetrahydronaphth-7-yl]-2E, 4E-heptadienoic acid (AGN194,204) or the PPAR pan-agonist WY-14,643 (WY; pirinixic acid) and compared with the profiles from the livers of wild-type and LXRalpha/LXRbeta-null mice after exposure to the LXR agonist N-(2,2,2-trifluoroethyl)N-[4-(2,2,2-trifluoro-1-hydroxy-1-trifluoromethylethyl) phenyl] sulfonamide (T0901317). All 218 WY-regulated genes altered in wild-type mice required PPARalpha. Remarkably, similar to80% of genes regulated by AGN194,204 required PPARalpha including cell-cycle genes, consistent with AGN-induced hepatocyte proliferation having both PPARalpha-dependent and -independent components. Overlaps of similar to31 to 62% in the transcript profiles of WY, AGN194,204, and T0901317 required PPARalpha and LXRalpha/LXRbeta for statistical significance. Of the 50 overlapping genes regulated by T0901317 and WY, all but one were regulated in a similar direction. These results 1) identify new transcriptional targets of PPARalpha and RXR important in regulating lipid metabolism and liver homeostasis, 2) illustrate the importance of PPARalpha in regulation of gene expression by a prototypical PP and by an RXR agonist, and 3) provide support for an axis of PPARalpha-RXR-LXR in which agonists for each nuclear receptor regulate an overlapping set of genes in the mouse liver.
引用
收藏
页码:1440 / 1452
页数:13
相关论文
共 40 条
[1]   Altered constitutive expression of fatty acid-metabolizing enzymes in mice lacking the peroxisome proliferator-activated receptor α (PPARα) [J].
Aoyama, T ;
Peters, JM ;
Iritani, N ;
Nakajima, T ;
Furihata, K ;
Hashimoto, T ;
Gonzalez, FJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1998, 273 (10) :5678-5684
[2]   On the concentrations of cyclins and cyclin-dependent kinases in extracts of cultured human cells [J].
Arooz, T ;
Yam, CH ;
Siu, WY ;
Lau, A ;
Li, KKW ;
Poon, RYC .
BIOCHEMISTRY, 2000, 39 (31) :9494-9501
[3]  
AUWERX J, 1996, ATHEROSCLEROSIS, V124, P29
[4]   Lobule-dependent zonal measurement (LZM) method for the determination of cell proliferation in the liver [J].
Bahnemann, R ;
Mellert, W .
EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY, 1997, 49 (3-4) :189-196
[5]   Differential expression of peroxisome proliferator-activated receptors (PPARs): Tissue distribution of PPAR-alpha, -beta, and -gamma in the adult rat [J].
Braissant, O ;
Foufelle, F ;
Scotto, C ;
Dauca, M ;
Wahli, W .
ENDOCRINOLOGY, 1996, 137 (01) :354-366
[6]   Central role of peroxisome proliferator-activated receptors in the actions of peroxisome proliferators [J].
Corton, JC ;
Anderson, SP ;
Stauber, A .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 2000, 40 :491-518
[7]   Peroxisome proliferator-activated receptor α negatively regulates the vascular inflammatory gene response by negative cross-talk with transcription factors NF-κB and AP-1 [J].
Delerive, P ;
De Bosscher, K ;
Besnard, S ;
Vanden Berghe, W ;
Peters, JM ;
Gonzalez, FJ ;
Fruchart, JC ;
Tedgui, A ;
Haegeman, G ;
Staels, B .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (45) :32048-32054
[8]  
Dorée M, 2002, J CELL SCI, V115, P2461
[9]   Cluster analysis and display of genome-wide expression patterns [J].
Eisen, MB ;
Spellman, PT ;
Brown, PO ;
Botstein, D .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (25) :14863-14868
[10]   Opposing mechanisms of NADPH-cytochrome P450 oxidoreductase regulation by peroxisome proliferators [J].
Fan, LQ ;
Coley, J ;
Miller, RT ;
Cattley, RC ;
Corton, JC .
BIOCHEMICAL PHARMACOLOGY, 2003, 65 (06) :949-959